Treatment Outcomes Associated With Dupilumab Use in Patients With Atopic Dermatitis
Treatment Outcomes Associated With Dupilumab Use in Patients With Atopic Dermatitis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Treatment Outcomes Associated With Dupilumab Use in Patients With Atopic Dermatitis have?
Treatment Outcomes Associated With Dupilumab Use in Patients With Atopic Dermatitis has 22 citations in the OpenAlex counts ScholarIQ stores.
When was Treatment Outcomes Associated With Dupilumab Use in Patients With Atopic Dermatitis published?
Treatment Outcomes Associated With Dupilumab Use in Patients With Atopic Dermatitis has 2021 year in the ScholarIQ index.
What is the open-access status of Treatment Outcomes Associated With Dupilumab Use in Patients With Atopic Dermatitis?
Treatment Outcomes Associated With Dupilumab Use in Patients With Atopic Dermatitis has hybrid oa status in the ScholarIQ index.
What is the DOI of Treatment Outcomes Associated With Dupilumab Use in Patients With Atopic Dermatitis?
The DOI for Treatment Outcomes Associated With Dupilumab Use in Patients With Atopic Dermatitis is on the source record.
What is the PMID of Treatment Outcomes Associated With Dupilumab Use in Patients With Atopic Dermatitis?
The PMID for Treatment Outcomes Associated With Dupilumab Use in Patients With Atopic Dermatitis is on the source record.
What is the OpenAlex record for Treatment Outcomes Associated With Dupilumab Use in Patients With Atopic Dermatitis?
The OpenAlex for Treatment Outcomes Associated With Dupilumab Use in Patients With Atopic Dermatitis is on the source record.